Tag: systemic sclerosis-associated interstitial lung disease

Glenmark Pharmaceuticals gets FDA approval for Nintedanib Capsules

Glenmark Pharmaceuticals Ltd said that it has secured tentative approval from the US Food and Drug Administration (FDA) for Nintedanib Capsules, 100mg, and 150mg. Nintedanib ... Read More